AdvanCell Isotopes Pty
AdvanCell Isotopes Pty is a startup headquartered in Sydney, Australia, founded in 2019. It has raised at least $5.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
AdvanCell Isotopes Pty has raised at least $5.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
AdvanCell Isotopes Pty sits inside the Sydney R&D ecosystem in the Global R&D Labs Directory.
Other startups in Sydney
Related
- Innovation profile of Sydney
- Australia: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does AdvanCell Isotopes Pty do?
AdvanCell Isotopes Pty is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has AdvanCell Isotopes Pty raised?
At least $5.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is AdvanCell Isotopes Pty based?
AdvanCell Isotopes Pty is headquartered in Sydney, Australia.
When was AdvanCell Isotopes Pty founded?
AdvanCell Isotopes Pty was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.